Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Formation of Lipopolysaccharides01:19

Formation of Lipopolysaccharides

Lipopolysaccharides (LPS) are crucial components of the outer membrane of Gram-negative bacteria, serving both structural and functional roles. It contributes to membrane stability and protects bacteria from host immune responses. LPS is composed of three major regions—lipid A, a core oligosaccharide, and an O antigen. The biosynthesis and assembly of LPS involve a highly coordinated set of enzymatic reactions and transport mechanisms. Additionally, LPS is recognized as an endotoxin, triggering...
Gram-negative Bacterial Protein Secretion Systems01:17

Gram-negative Bacterial Protein Secretion Systems

Gram-negative bacteria utilize sophisticated protein secretion systems to transport proteins across their double-membrane envelope into the extracellular environment or host cells. Based on their mechanism of action, these systems are classified into one-step and two-step pathways.One-Step Secretion Systems (Types I, III, IV, and VI)One-step secretion systems bypass the periplasm entirely, forming a continuous channel that spans both the inner and outer membranes:Type I Secretion System (T1SS):...
Outer Layers of the Cell Envelope01:18

Outer Layers of the Cell Envelope

The outermost layers of prokaryotic cells play a critical role in their survival, virulence, and interaction with the environment. These layers, often composed of polysaccharides, polypeptides, or proteins, form protective and adhesive structures that vary in organization and function.Capsules and Slime LayersCapsules are highly organized, tightly bound layers that firmly attach to the bacterial cell wall. Capsules are usually made of polysaccharides, though some are made of polypeptides. These...
Production of Pharmaceuticals01:30

Production of Pharmaceuticals

Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Discovery and characterization of an anti-<i>Neisseria gonorrhoeae</i> NGO_1985 monoclonal antibody and cognate antigen.

Frontiers in microbiology·2026
Same author

Development of flow cytometry bead-based opsonophagocytic assays to dissect cell-mediated functional antibody responses to malaria vaccines.

Malaria journal·2026
Same author

Development of a GMMA-based candidate vaccine against invasive nontyphoidal <i>Salmonella</i> disease.

Frontiers in immunology·2026
Same author

Understanding the impact of Klebsiella pneumoniae K-Antigen based MAPS vaccine design on the immune response in animal models.

PLoS pathogens·2026
Same author

GMMA as delivery system for Klebsiella pneumoniae O-antigens and K-antigens.

Scientific reports·2026
Same author

Immune response to rotavirus vaccines in low- and middle-income countries: Challenges and perspectives.

Human vaccines & immunotherapeutics·2026

Related Experiment Video

Updated: May 21, 2026

Directed Protein Packaging within Outer Membrane Vesicles from Escherichia coli: Design, Production and Purification
10:21

Directed Protein Packaging within Outer Membrane Vesicles from Escherichia coli: Design, Production and Purification

Published on: November 16, 2016

High yield production process for Shigella outer membrane particles.

Francesco Berlanda Scorza1, Anna Maria Colucci, Luana Maggiore

  • 1Novartis Vaccines Institute for Global Health, Siena, Italy.

Plos One
|June 16, 2012
PubMed
Summary
This summary is machine-generated.

Researchers developed a high-yield process for producing outer membrane particles from Shigella sonnei, a key step towards affordable vaccines derived from gram-negative bacteria.

More Related Videos

Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization
10:13

Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization

Published on: August 11, 2018

A High-throughput Shigella-specific Bactericidal Assay
06:11

A High-throughput Shigella-specific Bactericidal Assay

Published on: February 27, 2019

Related Experiment Videos

Last Updated: May 21, 2026

Directed Protein Packaging within Outer Membrane Vesicles from Escherichia coli: Design, Production and Purification
10:21

Directed Protein Packaging within Outer Membrane Vesicles from Escherichia coli: Design, Production and Purification

Published on: November 16, 2016

Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization
10:13

Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization

Published on: August 11, 2018

A High-throughput Shigella-specific Bactericidal Assay
06:11

A High-throughput Shigella-specific Bactericidal Assay

Published on: February 27, 2019

Area of Science:

  • Microbiology
  • Immunology
  • Biotechnology

Background:

  • Gram-negative bacteria naturally release outer membrane particles (OMPs).
  • OMPs are potential vaccine candidates, but low yields have hindered development.
  • Existing methods face challenges in scalable and cost-effective OMP production.

Purpose of the Study:

  • To develop a high-yield production process for genetically derived outer membrane particles from Shigella sonnei.
  • To assess the scalability and feasibility of this production method for manufacturing vaccines.
  • To explore genetic modifications for tailoring particle immunogenicity and reactogenicity.

Main Methods:

  • Engineered high-density fermentation of Shigella sonnei (ΔtolR ΔgalU) strains.
  • Optimization of fermentation conditions to achieve high optical densities (30-45).
  • Proteomic analysis to characterize the composition of purified outer membrane particles.

Main Results:

  • Achieved high yields of approximately 100 mg of membrane-associated proteins per liter.
  • Purified particles predominantly contained outer membrane and periplasmic proteins.
  • Demonstrated high immunogenicity of the particles in mouse models.
  • Showcased the potential for genetic manipulation to modify O-antigen and LPS structures.

Conclusions:

  • The developed process enables high-yield production of outer membrane particles from gram-negative bacteria.
  • This method supports scalable and affordable manufacturing of Generalized Modules of Membrane Antigens (GMMA) for vaccine development.
  • Genetic modifications offer a route to fine-tune vaccine properties, enhancing therapeutic potential.